Tarsus Pharmaceuticals, Inc.
TARSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Tarsus Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| J. Goldman & Co LP | 2026-03-31 | 14,541 | $1.02M | SEC filing |
| CAPSTONE INVESTMENT ADVISORS, LLC | 2026-03-31 | 3,799 | $267K | SEC filing |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 2026-03-31 | 4,126 | $289K | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 9,643 | $686K | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 3,793 | $266K | SEC filing |
| GABELLI FUNDS LLC | 2026-03-31 | 3,600 | $253K | SEC filing |
| Bayforest Capital Ltd | 2026-03-31 | 703 | $49.3K | SEC filing |
| Aquatic Capital Management LLC | 2026-03-31 | 8,985 | $630K | SEC filing |
| ARIZONA STATE RETIREMENT SYSTEM | 2026-03-31 | 8,745 | $613K | SEC filing |
| GHP Investment Advisors, Inc. | 2026-03-31 | 1 | $71 | SEC filing |
| Advisory Services Network, LLC | 2026-03-31 | 190 | $13.3K | SEC filing |
| FIFTH THIRD BANCORP | 2026-03-31 | 4,923 | $345K | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 163,997 | $11.5M | SEC filing |
| AMERIPRISE FINANCIAL INC | 2026-03-31 | 8,551 | $600K | SEC filing |
| Deep Track Capital, LP | 2026-03-31 | 3,600,000 | $253M | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 19,078 | $1.34M | SEC filing |
| Lisanti Capital Growth, LLC | 2026-03-31 | 41,815 | $2.93M | SEC filing |
| TANG CAPITAL MANAGEMENT LLC | 2026-03-31 | 1,188,624 | $83.4M | SEC filing |
| Paradigm Biocapital Advisors LP | 2026-03-31 | 2,562,154 | $180M | SEC filing |
| Clearbridge Investments, LLC | 2026-03-31 | 545,351 | $38.3M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Tarsus Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-16 · Farrow Jeffrey S: Larger than 69 of the 72 other insider sales of Common Stock on file. SEC filing
- 2026-03-19 · Azamian Bobak R.: Larger than 67 of the 72 other insider sales of Common Stock on file. SEC filing
- 2026-03-18 · Azamian Bobak R.: Larger than 66 of the 72 other insider sales of Common Stock on file. SEC filing
- 2026-03-17 · Azamian Bobak R.: Larger than 65 of the 72 other insider sales of Common Stock on file. SEC filing
- 2025-09-08 · LINK WILLIAM J PHD: Larger than 71 of the 72 other insider sales of Common Stock on file. SEC filing
- 2025-06-17 · Farrow Jeffrey S: Larger than 68 of the 72 other insider sales of Common Stock on file. SEC filing
- 2025-06-09 · Mottiwala Aziz: Larger than 70 of the 72 other insider sales of Common Stock on file. SEC filing
- 2024-08-12 · LINK WILLIAM J PHD: Larger than all 72 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-17 | Azamian Bobak R. · President/CEO and Board Chair | Common Stock | S — Open market or private sale | −4,582 | 61.24 | SEC filing |
| 2026-06-17 | Azamian Bobak R. · President/CEO and Board Chair | Common Stock | S — Open market or private sale | −5,418 | 61.81 | SEC filing |
| 2026-06-16 | Farrow Jeffrey S · See Remarks | Common Stock | S — Open market or private sale | −14,396 | 60.95 | SEC filing |
| 2026-06-15 | LINK WILLIAM J PHD · Director | Common Stock | S — Open market or private sale | −10,572 | 61.97 | SEC filing |
| 2026-06-15 | LINK WILLIAM J PHD · Director | Common Stock | S — Open market or private sale | −1,928 | 62.94 | SEC filing |
| 2026-06-15 | Goodrich Katherine · Director | Common Stock | S — Open market or private sale | −2,954 | 62.08 | SEC filing |
| 2026-03-20 | Neervannan Seshadri · Chief Operating Officer | Common Stock | S — Open market or private sale | −2,989 | 66.75 | SEC filing |
| 2026-03-19 | Whitfield Dianne C. · Chief Human Resources Officer | Common Stock | S — Open market or private sale | −4,174 | 67.00 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Morrison Scott W · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,837 | SEC filing |
| 2026-06-25 | LINK WILLIAM J PHD · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +806 | SEC filing |
| 2026-06-25 | Goodrich Katherine · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,837 | SEC filing |
| 2026-06-25 | YARNO WENDY L · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +2,417 | SEC filing |
| 2026-06-25 | YARNO WENDY L · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,837 | SEC filing |
| 2026-06-25 | Morrison Scott W · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +2,417 | SEC filing |
| 2026-06-25 | YARNO WENDY L · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +1,209 | SEC filing |
| 2026-06-25 | LINK WILLIAM J PHD · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,837 | SEC filing |
Showing 8 of 25 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-08-12 | LINK WILLIAM J PHD · Director | Common Stock | J — Other acquisition or disposition | +27,116 | SEC filing |
| 2024-08-12 | LINK WILLIAM J PHD · Director | Common Stock | J — Other acquisition or disposition | +10,446 | SEC filing |
| 2024-08-12 | LINK WILLIAM J PHD · Director | Common Stock | J — Other acquisition or disposition | −74,892 | SEC filing |
Showing 3 of 3 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.